-+ 0.00%
-+ 0.00%
-+ 0.00%

Kiniksa Pharmaceuticals Sees FY2026 Sales $900.000M-$920.000M vs $902.168M Est

Benzinga·02/24/2026 12:33:58
Listen to the news
Kiniksa Pharmaceuticals (NASDAQ:KNSA) sees FY2026 sales of $900.000 million-$920.000 million vs $902.168 million analyst estimate.